70 While the WHO-conducted trial showed no benefit in terms of survival in patients with COVID-19, 71 another study showed a shortening in the time to recovery in hospitalized adults and a nonsignificant trend also for improved survival at day 29 from hospitalization. 72 While the discussion regarding its benefit for COVID-19 management is far from being closed, remdesivir is being used in clinical practice in patients with severe forms of the disease.
1
—
—